Join us in the exploration of the causes, effects, and risk factors of HPV. This video will provide a general understanding of how HPV is transmitted, the health effects it can create (genital warts and cancer), and the forms of treatment and prevention for it (topical creams and vaccines). It will also address the importance of sociocultural taboos and stigma in preventing HPV and cervical cancer. This video is meant for a general mature audience aged 16 or older.
This video was made by McMaster Demystifying Medicine students Nazlim Bilgi, Pirouz Emami, Irzam Gondal, and Seyed Amirhossein Pishva.
Copyright McMaster University 2019.
References:
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., … Shan, K. V. (1995).
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective. JNCI Journal
of the National Cancer Institute, 87(11), 796-802. doi: 10.1093/jnci/87.11.796
Castellsagué, X. (2008). Natural history and epidemiology of HPV infection and cervical cancer.
Gynecologic Oncology, 110(3). doi: 10.1016/j.ygyno.2008.07.045
Chaturvedi, A. K. (2010). Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among
Men and Women. Journal of Adolescent Health, 46(4). doi: 10.1016/j.jadohealth.2010.01.016
Clifford, G. M., Smith, J. S., Aguado, T., & Franceschi, S. (2003). Comparison of HPV type
distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. British Journal of
Cancer, 89(1), 101-105. doi: 10.1038/sj.bjc.6601024
De Sanjosé, S., Serrano, B., Tous, S., Alejo, M., Lloveras, B., … Quirós, B. (2018). Burden of Human
Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58.
JNCI Cancer Spectrum, 2(4).doi:10.1093/jncics/pky045
Faridi, R., Zahra, A., Khan, K., & Idrees, M. (2011). Oncogenic potential of Human Papillomavirus
(HPV) and its relation with cervical cancer. Virology Journal, 8(1), 269. doi: 10.1186/1743-422x-
8-269
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., …
Koutsky, L. A. (2007). Quadrivalent Vaccine against Human Papillomavirus to Prevent
Anogenital Diseases. New England Journal of Medicine, 356(19), 1928-1943.
doi:10.1056/nejmoa061760
Lowy, D. R. (2016). HPV vaccination to prevent cervical cancer and other HPV-associated disease:
from basic science to effective interventions. Journal of Clinical Investigation, 126(1), 5-11. doi:
10.1172/jci85446
Martel, C. D., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer
attributable to HPV by site, country and HPV type. International Journal of Cancer, 141(4),
664-670. doi: 10.1002/ijc.30716
Saslow, D., Castle, P. E., Cox, J. T., Davey, D. D., Einstein, M. H., Ferris, D. G., … Garcia, F. (2007).
American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent
Cervical Cancer and Its Precursors. CA: A Cancer Journal for Clinicians, 57(1), 7-28. doi:
10.3322/canjclin.57.1.7
Wentzensen, N., Schiffman, M., Palmer, T., & Arbyn, M. (2016). Triage of HPV positive women in
cervical cancer screening. Journal of Clinical Virology, 76. doi: 10.1016/j.jcv.2015.11.015
Негізгі бет The most common STI in the world: HPV
No video
Пікірлер: 370